MGNX

Macrogenics INC

+$60.9M

Net Activity

Institutions Holding

108

Popularity Rank

#4296

Avg Weight

0.01%

Total Value

$125.2M

Ownership Trend

108 institutions currently hold MGNX, with 56 net buyers and 38 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

38

Net Buying Institutions

56

Key Holders

Key Holders

Top 5 by Value

AC
Armistice Capital, LLC
$17.4M
RT
Renaissance Technologies LLC
$8.6M
MM
Millennium Management LLC
$8.1M
VC
Vanguard Capital Management LLC
$7.7M
AA
Acadian Asset Management LLC
$7.3M

Top 5 by Conviction

AC
Armistice Capital, LLC
0.31%
DP
Diadema Partners LP
0.30%
PA
Persistent Asset Partners Ltd
0.16%
AA
Affinity Asset Advisors, LLC
0.07%
GC
Gsa Capital Partners LLP
0.07%
View all 108 holding institutions

Quarterly Activity

Recent Activity

+$76.8M

Total Buy Value

$28.2M

Total Sell Value

New buy28
Trim28
Add28
Sold out10

56

Net Buyers

38

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$76K

Total Est. Value

17K shares

Planned Shares

Last Filed 2026-07-13
FilerFiling DateEst. Value
Thomas Spitznagel2026-07-13$76K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

2

Filings (14d)

Data as of 2026-07-08
2026-07-08

MacroGenics disclosed today (July 1, 2026) that board member Dr. Karen Ferrante has resigned for personal reasons, effective September 1, 2026. The company emphasized that her departure is not related to any disagreement with the company's operations, policies, or practices, and thanked her for her contributions.

View Full Filing (SEC EDGAR)
2026-07-07

MacroGenics has completed the sale of its GMP manufacturing and CDMO operations to Bora Pharmaceuticals for $122.5 million before fees. The deal closed on June 30, 2026, and includes assets in Maryland.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding MACROGENICS INC (MGNX)?
Major stakeholders currently include Armistice Capital, LLC ($17.4M), Renaissance Technologies LLC ($8.6M), Millennium Management LLC ($8.1M). Based on the latest 13F filings, there are a total of 108 tracked investment funds and institutions maintaining positions in MGNX.
What is the overall institutional sentiment toward MGNX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $60.9M, driven by 56 managers accumulating shares while 38 reduced their exposure.
Which institutions have been selling or reducing their MGNX positions?
In the latest period, 28 funds trimmed their holdings, and 10 managers completely exited their positions. The aggregate reported sell value was $28.2M.
Are there any notable investors adding MGNX to their portfolios?
Yes, buying activity remains notable. 28 institutions opened new positions in {ticker}, and 28 existing holders added to their shares. The total reported buy value for the quarter amounted to $76.8M.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail